Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Feb;53(2):140-6.
doi: 10.1136/jcp.53.2.140.

A study of interval breast cancer within the NHS breast screening programme

Affiliations

A study of interval breast cancer within the NHS breast screening programme

W K Cowan et al. J Clin Pathol. 2000 Feb.

Abstract

Aim: To define the biological nature and malignant potential of interval cancers presenting to a breast unit within the NHS breast screening programme.

Methods: 112 interval cancers were compared with matched, screen detected and symptomatic cancers in terms of their radiographic, histopathological, and immunohistochemical features.

Results: Interval cancers, strictly defined, showed no characteristic radiographic pattern. In terms of size, vascular invasion, lymph node status, and prognosis they were intermediate between screen detected and symptomatic cancers. Within the interval cancers there was an excess of grade 1 and grade 3 tumours, and lesions with a high Ki67 index but immunohistochemistry otherwise failed to discriminate between the three groups. Inclusion of data from false negative "interval cancers" did not significantly alter the results.

Conclusions: Interval cancers are more aggressive than screen detected cancers but in general less aggressive than symptomatic cancers. However, within a heterogeneous group, occasional interval cancers are exceptionally malignant.

PubMed Disclaimer

References

    1. Br J Cancer. 1982 Mar;45(3):361-6 - PubMed
    1. J Pathol. 1998 Nov;186(3):254-61 - PubMed
    1. Surgery. 1983 Oct;94(4):543-7 - PubMed
    1. Breast Cancer Res Treat. 1985;6(3):221-7 - PubMed
    1. Lancet. 1986 Jul 5;2(8497):27-30 - PubMed